WHO ICTRP trial
Effect of Enoxaparin in treatment of neonate Thrombosis
IRCT20220122053794N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20220122053794N1 |
|---|---|
| Public title | Effect of Enoxaparin in treatment of neonate Thrombosis |
| Scientific title | Pilot study on feasibility and safety of administering weight-adjusted fixed low molecular weight heparin? |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 1-2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Dosage of enoxaparin in the treatment of neonatal thrombosis. |
| Interventions | Intervention 1: Preterm babies who receive a dose of enoxaparin 2 mg/kg twice a day subcutaneously. Intervention 2: Preterm infants who receive a dose of enoxaparin 1.7 mg/kg twice a day subcutaneously. |
| Registration date | Jul 2, 2022 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: